Symptom Burden Survey and Symptom Clusters in Chemotherapy Period of Lung Cancer

Author:

王 妍1,Fang Liyuan1,Zhou Kainan1,Xie Yi2,Yang shuhan2,Liu Suying1,Fang yuhang2,Wang runxi1,Sui Bailu2,Zhang Ying1

Affiliation:

1. Guang’anmen Hospital

2. Beijing University of Chinese Medicine

Abstract

Abstract Purpose The objective of the study was to research the symptom burden and symptom distribution characteristic of lung cancer patients during chemotherapy, identify the symptom clusters (SCs) and explore the mechanism of lung cancer specific SC, so as to provide evidence for clinical staff to manage symptoms and SCs. Methods All participants were recruited at the inpatient Oncology Department of Guang 'anmen Hospital, China Academy of Chinese Medical Sciences between July 2022 to December 2022. Investigate the incidence and severity of symptoms of lung cancer patients during chemotherapy. Exploratory factor analysis was used to identifySCs. SCs were identified for the mild, moderate and severe symptoms and for the moderate and severe symptoms respectively. Spearmen correlation analysis was used to analyze the correlation between lung cancer specific SC and blood routine index. Results A total of 169 patients participated in the study. The study found that, among the 43 symptoms, the most prevalent and the most serious symptoms was loss appetite. Based on the occurrence rate and severity of symptoms, SC extraction was performed for mild, moderate and severe symptoms with a symptom incidence more than 20%, and five SCs were identified, including psycho–emotion SC, chemotherapy related SC, lung cancer specific SC, urinary related SC, and gastrointestinal SC. For moderate and severe symptoms, two SCs were identified, including chemotherapy related SC and lung cancer specific SC and the lung cancer specific SC was negative correlation with eosinophils. Conclusion Patients with lung cancer during chemotherapy have complex and diverse symptoms. Based on different SC extraction methods, five SCs and two SCs were identified respectively. At the same time, the study explored the potential biological mechanism of lung cancer specific SC, and it was showed that lung cancer specific SC was related to eosinophils negatively. In the future, more research should be done on the research tools, research methods, pathogenesis and intervention measures of SCs.

Publisher

Research Square Platform LLC

Reference25 articles.

1. International Agency for Research on Cancer. Global Cancer Observatory: cancer today. World Health Organization. https://gco.iarc.fr/today (accessed Jan 19, 2020).

2. Lung cancer;Thai AA;Lancet,2021

3. Macrophages, inflammation, and lung cancer [J];CONWAY E M;Am J Respir Crit Care Med,2016

4. Pembrolizumab plus chemotherapy for squamous non–small-cell lung cancer[J];Paz-Ares L;New England Journal of Medicine,2018

5. Symptom management during and after treatment with concurrent chemoradiotherapy for oropharyngeal cancer: A review of the literature and areas for future research;Mason H;World J Clin Oncol,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3